BPC 157 + TB 500 10 mg
A catalogue BPC 157 and TB 500 combination; component amounts are undocumented.
CAD $90.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0027 Listed amount per vial: 10 mg Sales unit: 1 vial
Read the research in context.
A catalogue BPC 157 and TB 500 combination; component amounts are undocumented.
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration — source
- Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: The totals 10mg and 20mg do not establish equal component amounts. TB-500 nomenclature conflicts with full-length thymosin β4 in the wider market. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for BPC 157 + TB 500, product reference MRD-0027.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 10 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.